Global Oxygen Therapy Market – Overview

In recent years, there has been a growing prevalence of chronic respiratory diseases. These disorders include respiratory allergies, occupational lung diseases, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and asthma among others. The prevalence of these diseases has been on the rise across the globe, particularly among the low income and middle income nations. As per the findings of the World Health Organization (WHO), nearly 3 million people across the globe fall prey to COPD each year. This is highly alarming rate of growth, which has emerged as the chief driving factor for the adoption and growth of the oxygen therapy and hence the global oxygen therapy devices market. According to the research study conducted by Transparency Market Research, the global market for oxygen therapy devices is projected to reach a valuation worth US$2.8 Bn by the end of 2020.

Covid-19 to Have a Considerable Impact on Market Development

The market is expected to witness another prominent growth spike due to the outbreak of Covid-19 pandemic across the globe. Covid-19 is known to create breathing problems among patients. This is thus creating a huge demand for oxygen therapy and thus will provide a much deserved impetus to the overall development of the oxygen therapy devices market. The market is also expected grow due to the several advantages associated with oxygen therapy. Some of the key advantages of oxygen therapy are improved breathing patterns, better mental stamina, and lower risk of heart failure among others. Naturally, such wide range of benefits will also help in the development of the global oxygen therapy devices market in the coming years of the forecast period ranging from 2014 to 2020. The demand for oxygen therapy devices is projected to rise because of the latest developments and advancements in the medical procedures. With global healthcare industry widely acknowledging and adopting these developments, naturally, the market is expected to benefit from the same.

In recent years, the administration of hyperbaric oxygen therapy has emerged to be a huge challenge for medical professionals. Several governments have introduced multiple initiatives in order to enhance their hyperbaric therapy devices in their administrative areas. For instance, Hamad Medical Corporation (HMC) announced that the company has now joined a group of market leaders that offer services in emergency and trauma care. The company has introduced hyperbaric oxygen therapy devices in Qatar, and is projected to accumulate a solid consumer base in the regional market.

Liquid Oxygen Devices Segment to Witness Promising Growth

Based on the type of product, the global oxygen therapy devices market is segmented into oxygen delivery devices and oxygen source equipment. Liquid oxygen devices, concentrators, and cylinders are the key types of oxygen source equipment. Among these, the segment of oxygen concentrators has been the leading segment and account for a larger share in the global market. However, it is projected that the segment of liquid oxygen devices is expected to register a highly promising rate of growth in the coming years of the forecast period. This growth of the segment is primarily attributed to their growing application for the treatment of wide range of respiratory disorders. In addition to this, their improved and larger storage capacity is also a key factor in the development of liquid oxygen therapy devices segment.

The segment of oxygen delivery devices is further sub-segmented into continuous positive airway pressure (CPAP), simple oxygen masks, non-breather masks, bag valve masks, venturi masks, and nasal cannula. Among these, the segment of Venturi mask is expected to witness a promising rate of growth in the coming years of the forecast period.

In terms of application, there are wide range of segments of the global oxygen therapy devise market. Some of the key applications of oxygen therapy devices are treatment of cystic fibrosis, obstructive sleep apnea, pneumonia, respiratory distress syndrome, chronic obstructive pulmonary disease, and asthma among others. Among these, the segment of treatment for chronic obstructive pulmonary disease is expected to witness a promising demand in the coming years of the forecast period. The growth of the segment is primarily attributed to the increasing prevalence of COPD across the globe.

North America to Continue Having Stronghold on Global Market

Based on geography, there are five key regions of the global oxygen therapy devices market. These regional segments are North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Among these, the regional segment of North America has been the most dominant one in recent years. The growth of the regional segment is due to the presence of a matured and highly developed healthcare infrastructure. In addition to this, the growth of the segment is also attributed to the fact that region also enjoys early availability of latest technologies and product launches. Furthermore, increasing awareness among people in the region about the benefits of using oxygen therapy devices is also a key driving factor for the growth of the North America market.

On the other hand, the regional segment of Asia Pacific is expected to witness a highly promising growth in the coming years of the forecast period. The growth is fueled by the increasing investments in the development of the healthcare infrastructure in emerging economies such as India and China.

Some of the key companies operating in the global oxygen therapy devices market are AirSep Corporation, Philips Respironics, Inc., MAQUET Holding B.V. & Co. KG, ResMed, CareFusion Corporation, Teleflex Incorporated,Smiths Medical, Invacare Corporation, Fisher and Paykel Healthcare Limited, and DeVilbiss Healthcare LLC

Description: 

Oxygen therapy is a treatment that provides extra oxygen to lungs whenever a disease or respiratory condition is preventing them from getting enough oxygen. It is gaining popularity as one of the most reliable options used for the treatment of numerous types of respiratory diseases due to its supplementary, palliative, and definitive role. The administration of supplemental oxygen has become imperative for accurate management of various diseases. According to the National Institute of Health, oxygen therapy can potentially enhance the quality and length of life of individuals affected with chronic obstructive pulmonary diseases (COPD). Some of the benefits of this therapy are improved breathing pattern, increased mental stamina, and reduced risks of heart failure in people with severe respiratory disorders. The rising awareness regarding its benefits is fuelling the growth of the global oxygen therapy devices market. 

The report serves as a repository of analysis and information regarding various aspects of the global oxygen therapy devices market including value chain analysis, market dynamics, geographical segmentation, and competitive landscape. Historical data and current market scenario have been taken into account to derive the future trends anticipated in the market. 

Overview of the Global Oxygen Therapy Devices Market 

The increasing adoption of oxygen therapies as a treatment for various diseases including asthma, COPD, obstructive sleep apnea, and respiratory distress syndrome is driving the global oxygen therapy devices market. However, the shortage of proper reimbursement policies and presence of stringent regulations associated with oxygen therapy devices are likely to impede the growth of the market. 

The valuation of the global oxygen therapy devices market was US$1.9 bn in 2013 and is anticipated to rise to US$2.8 bn by 2020, expanding at a CAGR of 5.70% between 2014 and 2020. Geographically, North America was the leading market in terms of revenue in 2013. The growth of this region can be attributed to factors such as rising prevalence of life-threatening respiratory disorders, technological developments in the field of medical devices, increasing awareness regarding the benefits of oxygen therapy, and the presence of well-developed healthcare infrastructure. However, due to the presence of a large population, robust economic growth, and increasing government initiatives to promote healthcare, Asia Pacific is expected to exhibit a significant CAGR over the forecast period. 

On the basis of applications, the market is segmented into asthma, cystic fibrosis, chronic obstructive pulmonary disease, pneumonia, obstructive sleep apnea, and respiratory distress syndrome. The COPD segment will continue to dominate the market until 2020 owing to the increasing incidence of COPD across the globe and rising patient preference for oxygen therapy as their first treatment option. 

On the basis of product type, the market is categorized into two major segments: oxygen delivery devices and oxygen source equipment. The oxygen delivery devices segment is further segmented into bag valve masks, nasal cannula, CPAP masks, non-rebreather masks, and venturi masks. Out of these, venturi masks will dominate the market throughout the forecast period. The sub-segments of oxygen source equipment are liquid oxygen devices, oxygen concentrators, and oxygen cylinders. The liquid devices segment is estimated to rise at a noteworthy CAGR during the same period owing to the increasing need for improved storage capacity and greater mobility and its growing adoption for the treatment of various respiratory diseases. 

Companies Mentioned in the Global Oxygen Therapy Devices Market 

Some of the key players operating in the market are AirSep Corporation, CareFusion Corporation, Fisher & Paykel Healthcare Limited, DeVilbiss Healthcare, Invacare Corporation, MAQUET Holding B.V. & Co. KG, ResMed Inc., Respironics, Inc. (a Philips company), and Teleflex Incorporated. 

The global oxygen therapy devices market is segmented as follows: 

Oxygen Therapy Devices Market, by Product Type

  • Oxygen Source Equipment
    • Oxygen Cylinders
    • Oxygen Concentrators
    • Liquid Oxygen Devices
  • Oxygen Delivery Devices
    • Simple Oxygen Mask
    • Nasal Cannula
    • Venturi Mask
    • Non-rebreather Mask
    • Bag Valve mask
    • CPAP Mask

Oxygen Therapy Devices Market, by Applications

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma 
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome (RDS)
  • Cystic Fibrosis
  • Pneumonia

Oxygen Therapy Devices Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW) 

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Oxygen Therapy Market

Buy Now